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Quantitative assessment of bile ducts in turkeys 
treated with artemisinin  
 A model for liver toxicity? 
Background 
Development of resistance to anticoccidial drugs, removal of licensed antihistomonal formulations and a shift 
towards organic production has put the focus on natural occurring compounds for controlling protozoa 
infections in poultry.  
Artemisinin originates from Artemisia annua and is widely used as an efficient antimalarial in humans. 
Inhibitory activity against coccidia of chickens was reported previously; however, toxic side effects, i.e. 
degeneration of the brain, liver and kidney, also were induced. 
In a previous study investigating the effect of artemisinin against histomonosis in turkeys and chickens, 
artemisinin was administered in the feed to day-old turkeys (Thofner et al. 2012). As a result, sudden deaths 
occurred on day 5 and 6 in the group receiving 2600 mg artemisinin per kg feed, and the remaining birds in 
the group were then euthanized.  
The histological examination of haematoxylin and eosin stained sections indicated bile duct proliferation of 
the treated turkeys.  
In the present study we examined liver samples from the 15 dead/euthanized turkeys and 10 untreated and 
age-matched birds.  
 
Aim 
The aim was to quantify the volume fraction of bile duct epithelium and the number of bile duct profiles/area 
in turkeys suspected of artemisinin intoxication by unbiased stereology. 
 
Methodology  
Histological preparation 
• Paraffin embedded formalin-fixed liver samples from Artemisinin treated turkey chickens (5-7 days old, 
n=15) and untreated and age-matched birds (n=10) were cut into 4 μm thick sections.  
• Immunohistochemical detection of cytokeratin (Cytokeratin clone AE1/AE3, DAKO) was performed to 
distinguish the bile duct epithelium from liver parenchyma, connective tissue and blood vessels. Slides 
were counterstained with Mayers haematoxylin. 
Stereology 
• All fields of vision in all  25 sections were randomly selected within the delineated area of interest  in steps 
of 400 μm (dx=dy).  
• Determine the volume fraction of bile duct epithelium relative (Figure 1, red circles) to liver parenchyma 
using point grid counting (16 points per field of vision) 
• Presence of lumen was noted for the transected bile duct profiles in each counting frame (7709,6 μm2). 
The relative number of lumen-less bile duct profiles per total number of bile duct transects were estimated 
as a function of the total observed area.  
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Discussion 
The present findings suggest that metabolism or excretion of artemisinin in birds may take place in the liver. 
However, no analysis on bile or faecal matter was performed. 
The difference in the relative ratio of bile duct profiles without lumen may be explained by in a significant 
difference in the absolute number of bile duct profiles with lumen between treatments. Combined with the 
observed pleomorphic appearance of bile duct epithelium in artemisinin treated birds the present observation 
suggest that bile differentiation is abnormal as a response to toxic injury caused by artemisinin.  
Turkey fetuses has been evaluated as suitable for assessing in ovo carciogenicity showing hepatic changes 
similar to adult rodents (Williams, et al., 2011), however the histological evaluation is purely descriptive. This 
is the first study that uses stereological microscopy for quantification of bile duct epithelium in turkey livers.  
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Discoveries 
• No differences in the volume fraction of bile duct epithelium in relation to the volume of liver parenchyma 
between treatments (Table 1). 
• The ratio of bile duct profiles with no lumen of the artemisinin treated birds is significantly higher than the 
same ratio in the control birds (Table 1 and Figure 2). 
• The total number of counted profiles with or without lumen did not differ significantly between the two 
groups. Neither did the absolute number of bile duct profiles without lumen. 
• In the control bird the absolute number of bile duct profiles with lumen is significantly higher than in the 
artemisinin treated birds (P< 0,0001). 
• Epithelial anisocytosis and anisokaryosis  of bile epithelium was observed in the artemisinin treated group  
(Figure 3). 
Table 1. Quantitation of bile duct proliferation in Artemisinin treated turkey chickens and untreated control birds . 
Mean ± SEM values and unpaired t-test, p < 0,05 (significance level). 
Figure 3 Bile duct profiles without lumen (white arrows).  A) Control bird. B) Artemisinin treated bird. 
Note the pleomorphic appearance (anisocytosis and anisokaryosis; intracellular vacuoles)  and irregular 
organisation of the bile epithelium in artemisinin treated birds (B) compared to untreated birds.(A) (l: liver 
paranchyma; p: portal vessel ). (x60 objective, oil immersion. Total magnification: 3063x) 
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Conclusion 
• The present findings suggest that artemisinin treatment changes the differentiation of the 
biliary duct system.  
• The ratio of bile duct profiles with no lumen of the artemisinin treated birds is 
significantly higher than the same ratio in the control birds. 
• No differences in the volume fraction of bile duct epithelium in relation to the volume of 
liver parenchyma between treatments. 
• This is the first study that uses stereological microscopy for quantification of bile duct 
epithelium in turkey livers 
  
Control  
(n=10) 
Artemisinin  
(n=15) 
p-value 
Volume fraction  
(bile epithelium/liver parenchyma) 
0,01154 ± 0,0008389 0,01069 ± 0,0008334 0,4945 
Examined area (mm2) 2,655 ± 0,2039 2,201 ± 0,1146 0,0478 
Ratio: bile duct profiles no lumen/total no. 
of bile duct profiles 
0,7056 ± 0,02025 0,7899 ± 0,02071 0,0107 
Total no bile duct profiles/mm2 44,83 ± 3,114 39,59 ± 3,260 0,2808 
No. of bile duct profiles no lumen/ mm2 31,93 ± 2,744 31,79 ± 3,203 0,9768 
No. of bile duct profiles with lumen/ mm2 12,90 ± 0,9060 7,795 ± 0,6172 < 0,0001 
Figure 1: 16-point grid (black arrow) and counting frame (blue arrows) in a field of vision. p; portal vessel. Slide 
from Artemisinin treated bird (x60 objective, oil immersion. Total magnification: 3063x).  
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Figure 2 A) Ratio of bile duct profuiles no lumen/total number of bile duct profiles. B) Total number of bile duct 
profiles. C) Number of bile duct profiles without lumen. D) Bile duct profiles with lumen. *: significant difference 
between control group and artemisinin treated group.  
